These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2038795)

  • 21. Estrogen dosage and suppression of testosterone levels in patients with prostatic carcinoma.
    Kent JR; Bischoff AJ; Arduino LJ; Mellinger GT; Byar DP; Hill M; Kozbur X
    J Urol; 1973 May; 109(5):858-60. PubMed ID: 4699685
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hormonal treatments of prostate cancer].
    Kuhn JM
    Rev Prat; 1990 Nov; 40(25):2357-62. PubMed ID: 2124721
    [No Abstract]   [Full Text] [Related]  

  • 23. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ; Morales A
    Can J Surg; 1983 Sep; 26(5):434-8. PubMed ID: 6351988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphopenic response of patients presenting with chronic lymphocytic leukemia associated with carcinoma of the prostate to diethylstilbestrol: correlation of response to the in vitro synthesis of RNA by patient lymphocytes and its relationship to transcortin.
    Narasimhan P; Amaral L
    Am J Hematol; 1980; 8(4):369-75. PubMed ID: 7416164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hormones on the growth of virus-transformed hamster prostatic tissue.
    Fraley EE; Paulson DF
    Surg Forum; 1968; 19():544-5. PubMed ID: 4304976
    [No Abstract]   [Full Text] [Related]  

  • 26. Testosterone-induced activation of fibrinolysis in carcinoma of the prostate.
    Rosswick RP
    Br J Urol; 1967 Apr; 39(2):143-6. PubMed ID: 6025389
    [No Abstract]   [Full Text] [Related]  

  • 27. Fatal spontaneous tumor lysis syndrome in a patient with metastatic, androgen-independent prostate cancer.
    Lin CJ; Hsieh RK; Lim KH; Chen HH; Cheng YC; Wu CJ
    South Med J; 2007 Sep; 100(9):916-7. PubMed ID: 17902299
    [No Abstract]   [Full Text] [Related]  

  • 28. A study of the effects of radiation on prevention of gynaecomastia due to oestrogen therapy.
    Waterfall NB; Glaser MG
    Clin Oncol; 1979 Sep; 5(3):257-60. PubMed ID: 498617
    [No Abstract]   [Full Text] [Related]  

  • 29. [Recurrence of cancer of the prostate after initial treatment with diethylstilbestrol (DES) in a homogeneous series of 175 cases].
    Reziciner S
    Ann Urol (Paris); 1997; 31(4):213-24. PubMed ID: 9412346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of estrogen therapy on metastatic carcinoma of the prostate.
    Anikwe RM
    Int Surg; 1977 Oct; 62(10):532-6. PubMed ID: 591215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cancer of the lung metastatic from the prostate; disappearance of the radiological images after diethylstilbestrol therapy].
    MEYER A; HINAUT G; LIOT F
    Bull Mem Soc Med Hop Paris; 1951 Oct 19-26; 67(27-28):1190-5. PubMed ID: 14925878
    [No Abstract]   [Full Text] [Related]  

  • 32. The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.
    Goldenberg SL; Bruchovsky N; Rennie PS; Coppin CM
    J Urol; 1988 Dec; 140(6):1460-5. PubMed ID: 2973529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Thymidine- 3 H autoradiography of human prostate cytological biopsy specimens].
    Faul P; Rabes H
    Urologe A; 1972 Sep; 11(5):295-9. PubMed ID: 4116650
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of hepatic metastases. Our experience].
    Gosso P; Della Valle E; Caponi R; Giordanello V; Defilippi L
    Minerva Chir; 1988 Oct; 43(19):1621-3. PubMed ID: 2466222
    [No Abstract]   [Full Text] [Related]  

  • 35. Paraplegia and paraparesis due to prostatic cancer. Use of intravenous diethylstilbestrol diphosphate.
    Hawtrey CE; Welch MJ; Schmidt JD; Culp DA; Flocks RH
    Urology; 1974 Oct; 4(4):431-4. PubMed ID: 4423432
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experiences with Honvan therapy in carcinoma of the prostate].
    Joó GD
    Med Welt; 1966 Jan; 1():61-4. PubMed ID: 5942368
    [No Abstract]   [Full Text] [Related]  

  • 37. Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique.
    Byar DP; Mostofi FK
    Cancer; 1972 Jul; 30(1):5-13. PubMed ID: 5064808
    [No Abstract]   [Full Text] [Related]  

  • 38. [Letter: Hepatoma after prolonged estrogen therapy].
    Galanaud P; Chaput JC; Buffet C; Rain B
    Nouv Presse Med; 1976 Jan; 5(4):209. PubMed ID: 177949
    [No Abstract]   [Full Text] [Related]  

  • 39. Pulmonary manifestations of prostatic carcinoma.
    Lome LG; John T
    J Urol; 1973 Apr; 109(4):680-5. PubMed ID: 4695113
    [No Abstract]   [Full Text] [Related]  

  • 40. Porphyria cutanea tarda and estrogens.
    Vail JT
    JAMA; 1967 Aug; 201(9):671-4. PubMed ID: 6071822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.